LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review

OBJECTIVES: The aim of this study was to assess the current evidence for long-acting β(2)-agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combinations (FDCs) in the treatment of COPD. MATERIALS AND METHODS: A systematic literature search of randomized controlled trials published i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogliani, Paola, Calzetta, Luigino, Braido, Fulvio, Cazzola, Mario, Clini, Enrico, Pelaia, Girolamo, Rossi, Andrea, Scichilone, Nicola, Di Marco, Fabiano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174911/
https://www.ncbi.nlm.nih.gov/pubmed/30323582
http://dx.doi.org/10.2147/COPD.S170606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174911/
https://www.ncbi.nlm.nih.gov/pubmed/30323582
http://dx.doi.org/10.2147/COPD.S170606

Ejemplares similares